Related Experiment Video
Updated: Apr 7, 2026

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
Published on: August 26, 2025
Acute Stent Thrombosis During Glycoprotein IIb/IIIa Inhibitor Infusion.
Barbara Zdzierak1,2, Artur Dziewierz1,2, Krystian Gruszka1
1Clinical Department of Cardiology and Cardiovascular Interventions, University Hospital, Kraków, Poland.
Acute stent thrombosis (ST) is a rare but serious complication after percutaneous coronary intervention (PCI). This case highlights that even with imaging guidance and antiplatelet therapy, untreated downstream blockages can cause ST.
Area of Science:
- Cardiology
- Interventional Cardiology
- Biomedical Engineering
Background:
- Acute stent thrombosis (ST) is a critical complication occurring within 24 hours post-percutaneous coronary intervention (PCI).
- Inadequate antiplatelet therapy, stent underexpansion, or malapposition are commonly associated with ST.
- Intravascular imaging guidance aims to optimize PCI outcomes and reduce ST incidence.
More Related Videos
Related Concept Videos
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Venous Thrombosis III: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Cardiac Catheterization I: Pre-Procedure Overview

